Skip to main content
NUFORMIX PLC logo

NUFORMIX PLC — Investor Relations & Filings

Ticker · NFX ISIN · GB00BYW79Y38 LEI · 2138003XG3H3I2J3BJ24 IL Professional, scientific and technical activities
Open in API
Filings indexed 279 across all filing types
Latest filing 2025-05-29 Regulatory Filings
Country GB United Kingdom
Listing IL NFX

About NUFORMIX PLC

https://www.nuformix.com/

Nuformix PLC is a pharmaceutical development company focused on drug repurposing to address unmet medical needs, particularly in fibrosis and oncology. The company utilizes its expertise in cocrystal technology to unlock the therapeutic potential of approved drugs. This strategy involves creating new solid forms of existing medicines to improve their physical properties and performance, aiming to develop novel treatments with potentially accelerated development timelines.

Recent filings

Filing Released Lang Actions
Confirmation of European ODD for NXP002
Regulatory Filings Classification · 1% confidence The document is identified by the header 'RNS Number : 5029K' and concludes with standard boilerplate text from 'RNS, the news service of the London Stock Exchange.' RNS filings are general regulatory announcements. The content announces a specific corporate event: the granting of Orphan Drug Designation (ODD) by the EMA for a drug program (NXP002). This is a material, non-financial announcement typically disseminated via regulatory news services. Since it is a specific regulatory announcement that doesn't fit into categories like Director's Dealing (DIRS), Dividend Notice (DIV), or Earnings Release (ER), the most appropriate general regulatory category is RNS.
2025-05-29 English
Nuformix plc - Single prospectus
Capital/Financing Update Classification · 1% confidence The document explicitly identifies itself as a "prospectus relating to Nuformix plc" dated 23 May 2025. It details the approval process by the Financial Conduct Authority (FCA) under the Prospectus Regulation and discusses the proposed placing of new ordinary shares and their admission to the Official List and London Stock Exchange. A prospectus is a key document required for offering securities to the public, which aligns most closely with the definition of a document related to financing activities or a formal offering document. While it contains financial information, its primary purpose is the offering itself. This fits best under Capital/Financing Update (CAP) as it details a proposed placing and admission, which is a capital raising event. It is not a standard 10-K, AR, or IR, but a specific offering document. Reviewing the options: - 10-K: No, this is not an annual report. - AR: No, this is not a standalone audit report. - IR: No, this is not a comprehensive interim report. - CAP (Capital/Financing Update): This is highly relevant as it is a prospectus for a placing (fundraising) and admission to trading. - PSI (Proxy Solicitation & Information Statement): No, this is not soliciting votes for a meeting. Given the content is a formal Prospectus detailing a share placing and admission, CAP is the most appropriate classification for a document detailing a capital raising/financing event.
2025-05-28 English
Prospectus
Capital/Financing Update Classification · 1% confidence The document explicitly identifies itself as a "prospectus relating to Nuformix plc" dated 23 May 2025. It details the approval process by the Financial Conduct Authority (FCA) under the Prospectus Regulation and discusses the proposed placing of new ordinary shares and their admission to the Official List and London Stock Exchange. A prospectus is a key document required for offering securities to the public, which aligns most closely with the definition of a document related to financing activities or a formal offering document. While it contains financial information, its primary purpose is the offering itself. This fits best under Capital/Financing Update (CAP) as it details a proposed placing and admission, which is a capital raising event. It is not a standard 10-K, AR, or IR, but a specific offering document. Reviewing the options: - 10-K: No, this is not an annual report. - AR: No, this is not a standalone audit report. - IR: No, this is not a comprehensive interim report. - CAP (Capital/Financing Update): This is highly relevant as it is a prospectus for a placing (fundraising) and admission to trading. - PSI (Proxy Solicitation & Information Statement): No, this is not soliciting votes for a meeting. Given the content is a formal Prospectus detailing a share placing and admission, CAP is the most appropriate classification for a document detailing a capital raising/financing event.
2025-05-23 English
Publication of a Prospectus
Report Publication Announcement Classification · 1% confidence The document is a formal announcement released via RNS (RNS Number : 0231K) on May 23, 2025. The core subject is the 'Publication of Prospectus' related to a conditional share placing and the issuance of new ordinary shares. It explicitly mentions the publication of a Prospectus and provides details about the expected admission to trading on the London Stock Exchange. Since the document's primary function is to announce the availability and details of a formal regulatory document (the Prospectus) related to a capital change (share issuance), it fits the description of a Report Publication Announcement (RPA). Although it contains elements of capital change (SHA) and regulatory disclosure (RNS), the immediate action being reported is the publication of the Prospectus itself, making RPA the most precise fit, especially given the 'MENU VS MEAL' rule which favors announcements over the underlying document when the text is primarily an announcement.
2025-05-23 English
£210,000 Placing
Capital/Financing Update Classification · 1% confidence The document is an announcement from Nuformix PLC regarding a conditional placing of new ordinary shares to raise £210,000. It details the purpose of the funds, the conditions for the share issue, and the involvement of a placing agent. This falls under the category of capital raising and financing activities, which is explicitly defined as 'CAP' (Capital/Financing Update).
2025-05-22 English
Attendance at American Thoracic Society Congress
Regulatory Filings Classification · 1% confidence The document is a press release distributed via the RNS Reach service regarding a company's attendance at a medical congress and the presentation of research data. It does not fit into specific financial reporting categories like 10-K, IR, or ER, nor is it a report publication announcement. As it is a general corporate announcement regarding business activities, it falls under the RNS (Regulatory Filings) category.
2025-05-19 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.